{"id":859,"date":"2020-01-22T13:37:01","date_gmt":"2020-01-22T13:37:01","guid":{"rendered":"https:\/\/www.bioevents.net\/leukemia2020\/?page_id=859"},"modified":"2020-01-22T13:37:21","modified_gmt":"2020-01-22T13:37:21","slug":"abstract-topics","status":"publish","type":"page","link":"https:\/\/euroleuk.com\/abstract-topics\/","title":{"rendered":"Abstract Topics"},"content":{"rendered":"<ul>\n<li>Biology of ALL, AML, CML, CLL<\/li>\n<li>Leukemia stem cells (LSCs)<\/li>\n<li>Routing diagnosis gene expression and mutational profiling<\/li>\n<li>Allogeneic hematopoietic stem cell transplantation<\/li>\n<li>Front-line treatment of ALL, AML, CML, CLL<\/li>\n<li>Treatment of resistant\/relapsed disease<\/li>\n<li>How novel agents are changing the treatment landscape of ALL, AML, CML and CLL<\/li>\n<li>Immunotherapy<\/li>\n<li>Minimal residual disease<\/li>\n<li>Clinical Cases (Case) Reports<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Biology of ALL, AML, CML, CLL Leukemia stem cells (LSCs) Routing diagnosis gene expression and mutational profiling Allogeneic hematopoietic stem cell transplantation Front-line treatment of ALL, AML, CML, CLL Treatment of resistant\/relapsed disease How novel agents are changing the treatment landscape of ALL, AML, CML and CLL Immunotherapy Minimal residual disease Clinical Cases (Case) Reports<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-859","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abstract Topics - Euroleuk2020<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/euroleuk.com\/abstract-topics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abstract Topics - Euroleuk2020\" \/>\n<meta property=\"og:description\" content=\"Biology of ALL, AML, CML, CLL Leukemia stem cells (LSCs) Routing diagnosis gene expression and mutational profiling Allogeneic hematopoietic stem cell transplantation Front-line treatment of ALL, AML, CML, CLL Treatment of resistant\/relapsed disease How novel agents are changing the treatment landscape of ALL, AML, CML and CLL Immunotherapy Minimal residual disease Clinical Cases (Case) Reports\" \/>\n<meta property=\"og:url\" content=\"https:\/\/euroleuk.com\/abstract-topics\/\" \/>\n<meta property=\"og:site_name\" content=\"Euroleuk2020\" \/>\n<meta property=\"article:modified_time\" content=\"2020-01-22T13:37:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/euroleuk.com\/abstract-topics\/\",\"url\":\"https:\/\/euroleuk.com\/abstract-topics\/\",\"name\":\"Abstract Topics - Euroleuk2020\",\"isPartOf\":{\"@id\":\"https:\/\/euroleuk.com\/#website\"},\"datePublished\":\"2020-01-22T13:37:01+00:00\",\"dateModified\":\"2020-01-22T13:37:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/euroleuk.com\/abstract-topics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/euroleuk.com\/abstract-topics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/euroleuk.com\/abstract-topics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/euroleuk.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abstract Topics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/euroleuk.com\/#website\",\"url\":\"https:\/\/euroleuk.com\/\",\"name\":\"Euroleuk2020\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/euroleuk.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abstract Topics - Euroleuk2020","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/euroleuk.com\/abstract-topics\/","og_locale":"en_US","og_type":"article","og_title":"Abstract Topics - Euroleuk2020","og_description":"Biology of ALL, AML, CML, CLL Leukemia stem cells (LSCs) Routing diagnosis gene expression and mutational profiling Allogeneic hematopoietic stem cell transplantation Front-line treatment of ALL, AML, CML, CLL Treatment of resistant\/relapsed disease How novel agents are changing the treatment landscape of ALL, AML, CML and CLL Immunotherapy Minimal residual disease Clinical Cases (Case) Reports","og_url":"https:\/\/euroleuk.com\/abstract-topics\/","og_site_name":"Euroleuk2020","article_modified_time":"2020-01-22T13:37:21+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/euroleuk.com\/abstract-topics\/","url":"https:\/\/euroleuk.com\/abstract-topics\/","name":"Abstract Topics - Euroleuk2020","isPartOf":{"@id":"https:\/\/euroleuk.com\/#website"},"datePublished":"2020-01-22T13:37:01+00:00","dateModified":"2020-01-22T13:37:21+00:00","breadcrumb":{"@id":"https:\/\/euroleuk.com\/abstract-topics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/euroleuk.com\/abstract-topics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/euroleuk.com\/abstract-topics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/euroleuk.com\/"},{"@type":"ListItem","position":2,"name":"Abstract Topics"}]},{"@type":"WebSite","@id":"https:\/\/euroleuk.com\/#website","url":"https:\/\/euroleuk.com\/","name":"Euroleuk2020","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/euroleuk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages\/859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/comments?post=859"}],"version-history":[{"count":1,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages\/859\/revisions"}],"predecessor-version":[{"id":860,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages\/859\/revisions\/860"}],"wp:attachment":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/media?parent=859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}